Exane Derivatives’s Perrigo PRGO Stock Holding History

Exane Derivatives’s Portfolio PRGO Stock Details PRGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-842	Closed	-$32.4K	–	888
2022 Q1	$32.4K	Buy	+842	New	+$32.1K	0.01%	619

Other funds holding PRGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Exane Derivatives's PRGO Position: Q2 2022 in Review

Exane Derivatives sold out of Perrigo (PRGO) in Q2 2022, closing a stake of 842 shares — an estimated $32.4K sold.

Exane Derivatives first reported a position in PRGO in Q1 2022 and held it in 1 quarter. The position peaked at $32.4K in Q1 2022. 336 funds tracked by Wall St. Rank hold PRGO as of Q2 2022.

Exane Derivatives reported no remaining Perrigo position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 842 Perrigo shares in Q2 2022, an estimated $32.4K.
Exane Derivatives first reported a position in Perrigo in Q1 2022 and held it in 1 quarter.
Exane Derivatives's Perrigo position peaked at $32.4K in Q1 2022.
336 funds tracked by Wall St. Rank held Perrigo as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.